Next Steps for Immunotherapy in Glioblastoma

Next Steps for Immunotherapy in Glioblastoma

Outcomes for glioblastoma (GBM) patients undergoing standard of care treatment remain poor. Here we discuss the portfolio of previously investigated immunotherapies for glioblastoma, including vaccine therapy and checkpoint inhibitors, as well as novel emerging therapeutic approaches. In addition, w...

Full description

Bibliographic Details
Main Authors: Toni Q. Cao, Derek A. Wainwright, Catalina Lee-Chang, Jason Miska, Adam M. Sonabend, Amy B. Heimberger, Rimas V. Lukas
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Cancers
Subjects:
immunotherapy
glioblastoma
immune system
Online Access:https://www.mdpi.com/2072-6694/14/16/4023

Internet

https://www.mdpi.com/2072-6694/14/16/4023

Similar Items